Scheme 1
.
Generating Ynamido-Metal Complexes
Table 1. Effect of Equivalents of Amine and Pd(0) Sources
ynamido-metal complexes captured our attention. Conse-
quently, we examined a different pathway that can provide
general access to ynamido-metal π-allyl complexes 5a and
5b from N-allyl-N-sulfonyl ynamides 4. We report here a
de novo synthesis of pharmacologically useful amidines15-18
from ynamides featuring a palladium-catalyzed N-to-C allyl
transfer through ynamido-π-allyl complexes.
a All are isolated yields.
(7) (a) Al-Rashid, Z. F.; Johnson, W. L.; Hsung, R. P.; Wei, Y.; Yao,
P.-Y.; Liu, R.; Zhao, K. J. Org. Chem. 2008, 73, 8780. (b) Yao, P.-Y.;
Zhang, Y.; Hsung, R. P.; Zhao, K. Org. Lett. 2008, 10, 4275. (c) Zhang,
X.; Hsung, R. P.; Li, H.; Zhang, Y.; Johnson, W. L.; Figueroa, R. Org.
Lett. 2008, 10, 3477. (d) Al-Rashid, Z. F.; Hsung, R. P. Org. Lett. 2008,
10, 661. (e) Oppenheimer, J.; Hsung, R. P.; Figueroa, R.; Johnson, W. L.
Org. Lett. 2007, 9, 3969. (f) You, L.; Al-Rashid, Z. F.; Figueroa, R.; Ghosh,
S. K.; Li, G.; Lu, T.; Hsung, R. P. Synlett 2007, 1656. (g) Li, H.; You, L.;
Zhang, X.; Johnson, W. L.; Figueroa, R.; Hsung, R. P. Heterocycles 2007,
74, 553. (h) Sagamanova, I. K.; Kurtz, K. C. M.; Hsung, R. P. Org. Synth.
2007, 84, 359. (i) Oppenheimer, J.; Johnson, W. L.; Tracey, M. R.; Hsung,
R. P.; Yao, P.-Y.; Liu, R.; Zhao, K. Org. Lett. 2007, 9, 2361.
(8) Wu, P.; Feldman, A. K.; Nugent, A. K.; Hawker, C. J.; Scheel, A.;
Voit, B.; Pyun, J.; Frechet, J. M. J.; Sharpless, K. B.; Fokin, V. V. Angew.
Chem., Int. Ed. 2004, 43, 3928.
While identifying a suitable palladium catalyst for our
intended reaction pathway was not difficult, we found two
amidine products. As shown in Table 1, when treating
N-allyl-N-sulfonyl ynamide 6 with 5 mol % of Pd(PPh3)2Cl2
in the presence of c-hex-NH2 in THF at 65 °C, both amidines
7 and 8 were observed.19 Intriguingly, the ratio of 7 and 8
depended upon the amount of c-hex-NH2 that was used. A
greater amount of c-hex-NH2 (3-5 equiv) predominantly led
to the formation of 7 in which the allyl group is lost (entries
1 and 2), while 1.0 equiv of c-hex-NH2 and/or addition with
the use of syringe pump began to favor the formation of 8
in which the allyl group had undergone an N-to-C transfer
(entries 3 and 4).
(9) Zhang, X.; Hsung, R. P.; Li, H. Chem. Commun. 2007, 2420.
(10) For related studies on these triazolyl copper intermediates, see: (a)
Gerard, B.; Ryan, J.; Beeler, A. B.; Porco, J. A., Jr. Tetrahedron 2006, 62,
6405. (b) Wu, Y. M.; Deng, J.; Li, Y.; Chen, Q.-Y. Synthesis 2005, 1314.
(c) Cassidy, M. P.; Raushel, J.; Fokin, V. V. Angew. Chem., Int. Ed. 2006,
45, 3154. See footnote 11. .
Moreover, a quick screening of palladium sources revealed
that the allyl transfer is catalyst dependent (Table 1). At 3.0
equiv of c-hex-NH2 in comparison with Pd(PPh3)2Cl2 (see entry
1), Pd(PPh3)4 gave exclusively allyl-transferred amidine 8 (entry
5), while Pd(dppe)Cl2 and Pd(dppf)Cl2 (entries 6 and 7) reverted
back to favor amidine 7 with Pd(dppf)Cl2 giving a better yield
(entry 7). Sensing that these contrasts could be due to the
differences either in the initial oxidation state of the palladium
metal or, more likely, their respective ligands, we examined
(11) For intermolecular additions, see: (a) Bae, I.; Han, H.; Chang, S.
J. Am. Soc. Chem. 2005, 127, 2038. (b) Cho, S. H.; Yoo, E. J.; Bae, I.;
Chang, S. J. Am. Chem. Soc. 2005, 127, 16046. (c) Yoo, E. J.; Bae, I.;
Cho, S. H.; Han, H.; Chang, S. Org. Lett. 2006, 8, 1347. (d) Kim, S. H.;
Jung, D. Y.; Chang, S. J. Org. Chem. 2007, 72, 9769. (e) Cho, S. H.; Chang,
S. Angew. Chem., Int. Ed. 2008, 47, 2836. (f) Kim, J.; Lee, S. Y.; Lee, J.;
Do, Y.; Chang, S. J. Org. Chem. 2008, 73, 9454. (g) Yoo, E. J.; Ahlquist,
M.; Bae, I.; Sharpless, K. B.; Fokin, V. V.; Chang, S. J. Org. Chem. 2008,
73, 5520.
(12) For an intramolecular addition, see: Chang, S.; Lee, M.; Jung, D. Y.;
Yoo, E. J.; Cho, S. H.; Han, S. K. J. Am. Soc. Chem. 2006, 128, 12366.
(13) For a study using ynamides, see: Kim, J. Y.; Kim, S. H.; Chang,
S. Tetrahedron Lett. 2008, 49, 1745.
(14) For other leading examples of trapping complexes such as 3, see:
(a) Cui, S.-L.; Lin, X.-F.; Wang, Y.-G. Org. Lett. 2006, 8, 4517. (b) Xu,
X.; Cheng, D.; Li, J.; Guo, H.; Yan, J. Org. Lett. 2007, 9, 1585. (c) Jin, Y.;
Fu, H.; Yin, Y.; Jiang, Y.; Zhao, Y. Synlett 2007, 901. (d) Cui, S.-L.; Wang,
J.; Wang, Y.-G. Org. Lett. 2007, 9, 5023. (e) Cui, S.-L.; Wang, J.; Wang,
Y.-G. Org. Lett. 2008, 10, 1267. (f) For an earlier study on trapping of
ynamido-lithium complexes, see: Fromont, C.; Masson, S. Tetrahedron
1999, 55, 5405.
(17) Dunn, P. J. In ComprehensiVe Organic Functional Group Trans-
formations II, Amidines and N-Substituted Amidines; Katritzky, A. R.,
Taylor, R. J. K., Eds.; Pfizer Global Research and Development: Sandwich,
U.K., 2005; Vol. 5, pp 655-699.
(18) For recent examples of amidine synthesis, see: (a) Yu, R. T.; Rovis,
T. J. Am. Chem. Soc. 2008, 130, 3262. (b) Wang, J.; Xu, F.; Cai, T.; Shen,
Q. Org. Lett. 2008, 10, 445. (c) Malik, H.; Frederic, B.; Alexandre, M.;
Jean-Jacques, B. Org. Biomed. Chem. 2006, 4, 3142. (d) Katritzky, A. R.;
Cai, C.; Singh, S. K. J. Org. Chem. 2006, 71, 3375. (e) Kumagai, N.;
Matsunaga, S.; Shibasaki, M. Angew. Chem., Int. Ed. 2004, 43, 478.
(19) See the Supporting Information. On the basis of NOE experiments
(see the Supporting Information for details), these amidines adopt an
E-geometry with respect to the CdN bond.
(15) Greenhill, J. V.; Lue, P. Prog. Med. Chem. 1993, 30, 203
.
(16) For a leading review on amidine derivatives serving as selective
muscarinic agonists in the treatment of Alzheimer’s diseases, see: Messer,
W. S., Jr.; Dunbar, P. G. In Muscarinic Agonists and the Treatment of
Alzheimer’s Disease; Landes Bioscience: Georgetown, TX, 1996; pp
131-153.
900
Org. Lett., Vol. 11, No. 4, 2009